↓ Skip to main content

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC

Overview of attention for article published in Frontiers in oncology, June 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
7 Mendeley